Kieran T. Gallahue
Independent DirectorMr. Kieran T. Gallahue serves as Executive Chairman at Vantive Health LLC since 2026 and served as Chairman of the Board until 2026. Mr. Gallahue was Director of Nucleus Biologics LLC until 2024. Mr. Gallahue is a Founder at Atmas Health. He was Interim President and Chief Executive Officer at Intersect ENT, Inc. since June 5, 2019 through July 2019 and was its Executive Chairman since May 7, 2019 to April 2020. He served as Director at Systems Oncology, LLC until 2024. Mr. Gallahue had been an Independent Director at Arena Pharmaceuticals, Inc. since July 10, 2018 until March 11, 2022. He has been an Independent Director of Envista Holdings Corporation since December 18, 2019. He served as the Chairman and Chief Executive Officer of CareFusion Corporation at Becton Dickinson Rowa Germany GmbH (formerly known as CareFusion Germany 326 GmbH) from January 2011 to March 17, 2015. He served as Interim Chief Executive Officer and President of Intersect ENT, Inc. since June 5 2019 until July 22, 2019. Mr. Gallahue served as the Chief Executive Officer of ResMed Inc. from January 1, 2008 to January 28, 2011 and also as its President from September 2004 to January 28, 2011. He serves as Member of Advisory Council at Capsule Technologies, Inc. He served as the President of ResMed Global since October 2004 and also served as its Chief Executive Officer since 2008. He has many years of strategic, operational and corporate management experience in the healthcare industry, with deep expertise in the medical technologies field. He served as the President and Chief Operating Officer for Americas of ResMed Corp., a subsidiary of ResMed Inc., from January 13, 2003 to September 7, 2004. He joined ResMed in 2003. He held various general management and functional roles at GE. From 1997 to 2003, he served in various capacities with Nanogen, Inc. He served as the President of Nanogen Inc. (alternate name, Ngen, Inc.) and SynX Pharma Inc. from September 2000 to January 2, 2003. He served as the Chief Financial Officer of Nanogen Inc. from July 1999 to April 2001 and as its Senior Vice President from July 1999 to September 2000 and as Vice President of Strategic Marketing, from January 1998 to July 1999. From 1995 to 1997, he served as Vice President of the Critical Care Business Unit for Instrumentation Laboratory, or IL, where he was responsible for the worldwide strategic sales and marketing and research and development efforts for this business unit. From 1992 to 1995, he served a variety of sales and marketing positions within IL. In addition, he served various marketing positions within The Procter & Gamble Company from 1991 to 1992 and the General Electric Company from 1985 to 1989. He served with Proctor and Gamble. He has been an Independent Director of Edwards Lifesciences Corporation since February 10, 2015. He was a Lead Director of Intersect ENT, Inc. since April 2015 to May 7, 2019. He served as Director of Intersect ENT, Inc. since April 2015 until 2022 and served as Non-Executive Chairman since April 30, 2020 until 2022. He serves as a Member of Advisory Council at Qualcomm Life, Inc. He served as a Director at ResMed Inc. from January 1, 2008 to January 25, 2011 and CareFusion Corporation from January 2011 to March 17, 2015. He serves as Chief Executive Officer of CareFusion. He also served as a Director of ResMed Global since 2008 until 2011. He served as a Director of Volcano Corporation from July 17, 2007 until 2015. He served on the boards of Signifier Medical Technologies and Nucleus Biologics. He has been a Member of the Young President Organization since 2002. Mr. Gallahue received a B.A. Degree in Economics from Rutgers University (1981-1985) and an MBA from Harvard Business School (1989-1991).
Positions
- Company NameEnvista Holdings CorporationStock CodeNVSTPositionIndependent DirectorColleagues
- PAPaul A. KeelPresident, CEO & Chairman
- EDEric D. HammesSenior VP & CFO
- MEMark E. NanceSenior VP, General Counsel & Secretary
- RBRobert BefidiSenior VP & President of Diagnostics
- VAVeronica AcurioSenior VP & President of Orthodontics
- WCWendy CarruthersIndependent Director
- CAChristine A. TsingosIndependent Director
- KTKieran T. GallahueIndependent Director
- RSRichard Scott HuennekensLead Independent Director
- Company NameEdwards Lifesciences CorporationStock CodeEWPositionIndependent DirectorColleagues
- BJBernard J. ZovighianCEO & Director
- NJNicholas J. ValerianiIndependent Chairman
- DEDonald E. BoboCorporate Vice President of Strategy & Corporate Development
- DCDaveen ChopraCorporate Vice President of Transcatheter Mitral & Tricuspid Therapies
- AMAnnette Maria BrulsCorporate Vice President of EMEA, Canada, & Latin America
- TMTheodora MistrasCorporate VP & CFO
- LSLeslie Stone HeiszIndependent Director
- PAPaul Arthur LaVioletteIndependent Director
